IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Lonza to Build Cell Therapy Production Facility in Singapore

7:54 AM MDT | May 25, 2009 | DEEPTI RAMESH

Lonza says it will build a cell therapy facility in Singapore to expand its global presence and meet growing worldwide demand. Lonza will invest SF30 million ($27 million) in the first construction phase of the plant, which will be located adjacent to Lonza’s large-scale mammalian cell culture facility at Tuas Biomedical Park. Construction is expected to begin in early 2010, with start up of two suites by mid-2011. Borgas: Cell therapy to become important innovation driver. The facility will be designed to accommodate additional suites to meet...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa